Telix Pharmaceuticals Ltd

NEW
STU:T3X (Australia)   Ordinary Shares
€ 11.1 +0.098 (+0.89%) Sep 18
129.63
P/B:
8.82
Market Cap:
€ 3.76B ($ 4.31B)
Enterprise V:
€ 4.05B ($ 4.64B)
Volume:
210.00
Avg Vol (2M):
2.30K
Trade In:

Telix Pharmaceuticals Ltd (STU:T3X) Dividend

Telix Pharmaceuticals Ltd (STU:T3X) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -2.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:T3X Dividend

Does Telix Pharmaceuticals Ltd (STU:T3X) pay a dividend?

Telix Pharmaceuticals Ltd (STU:T3X) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Telix Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Telix Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of -2.3% over the past 3 years.

What are dividend-paying alternatives to Telix Pharmaceuticals Ltd?

For dividend-paying alternatives in Telix Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.